• 3407 引用
  • 30 h指数
1991 …2020

年単位の研究成果

Pureに変更を加えた場合、すぐここに表示されます。

研究成果

フィルター
Letter
2019

From the authors

Kwak, N., Dalcolmo, M. P., Daley, C. L., Eather, G., Hasegawa, N., Koh, W. J., Thomson, R., Van Ingen, J. & Yim, J. J., 2019 11 1, : : European Respiratory Journal. 54, 5, 1901508.

研究成果: Letter

公開

Recovery of FRI-5 carbapenemase at a Japanese hospital where FRI-4 carbapenemase was discovered

Uwamino, Y., Kubota, H., Sasaki, T., Kosaka, A., Furuhashi, M., Uno, S., Kudoh, J., Murata, M. & Hasegawa, N., 2019 11 1, : : Journal of Antimicrobial Chemotherapy. 74, 11, p. 3390-3392 3 p.

研究成果: Letter

1 引用 (Scopus)
2018

Estimating latent tuberculosis infection using interferon-γ release assay, Japan

Nishimura, T., Ota, M., Mori, M., Hasegawa, N., Kawabe, H. & Kato, S., 2018 11 1, : : Emerging Infectious Diseases. 24, 11, p. 2111-2113 3 p.

研究成果: Letter

Mycobacterium triplex pulmonary disease with acquired macrolide resistance in immunocompetent patients

Matsuda, S., Suzuki, S., Morimoto, K., Aono, A., Nishio, K., Asakura, T., Sasaki, Y., Namkoong, H., Nishimura, T., Ogata, H., Hasegawa, N., Kurashima, A., Ishii, M., Tatsumi, K., Mitarai, S. & Goto, H., 2018 6 1, : : Clinical Microbiology and Infection. 24, 6, p. 671-672 2 p.

研究成果: Letter

1 引用 (Scopus)
2017

Disseminated Mycobacterium genavense infection in patient with adult-onset immunodeficiency

Asakura, T., Namkoong, H., Sakagami, T., Hasegawa, N., Ohkusu, K. & Nakamura, A., 2017 7, : : Emerging Infectious Diseases. 23, 7, p. 1208-1210 3 p.

研究成果: Letter

7 引用 (Scopus)
2000

Genetic variants of NRAMP1 and active tuberculosis in Japanese populations

Gao, P. S., Fujishima, S., Mao, X. Q., Remus, N., Kanda, M., Enomoto, T., Dake, Y., Bottini, N., Tabuchie, M., Hasegawa, N., Yamaguchib, K., Tiemessenf, C., Hopkina, J. M., Shirakawa, T. & Kishie, F., 2000 8 2, : : Clinical Genetics. 58, 1, p. 74-76 3 p.

研究成果: Letter

113 引用 (Scopus)